In Restem, LLC v. Jadi Cell, LLC, No. 2023-2054 (Fed. Cir. Mar. 13, 2025), the Federal Circuit upheld the Patent Trial and Appeal Board’s ...

The Federal Circuit says that you must disclose and describe the prior art, or your Jepson claim is invalid. Obviously, this ...

Q4 2024 Earnings Call Transcript March 13, 2025 Vuzix Corporation misses on earnings expectations. Reported EPS is $-0.16 EPS, expectations were $-0.12. Operator: Greetings, and welcome to the Vuzix ...

As 2025 unfolds, changes across the patent landscape are unfolding. From agency leadership transitions to proposed legislation and evolving ...

Some three years after the University of Pennsylvania claimed four of Roche’s breast cancer meds infringed its intellectual ...

Operator: Good afternoon, and welcome to the Evoke Pharma, Inc. Fourth Quarter and Full Year 2024 Earnings Conference Call. Currently, all callers have been placed in a listen-only mode.